JPAC
Joint United Kingdom (UK) Blood Transfusion and Tissue Transplantation Services Professional Advisory Committee
About JPAC
Latest Updates
Document Library
Useful Links
Contact Us
Search
Guidelines for the Blood
Transfusion Services
Welcome
Latest Updates
Publication Information
Figures
Tables
Preface
Change Notifications
Contents
1: Introduction
2. Quality in blood and tissue establishments and hospital blood banks
3: Care and selection of whole blood and component donors (including donors of pre-deposit autologous blood)
4: Premises and quality assurance at blood donor sessions
5: Collection of a blood or component donation
6: Evaluation and manufacture of blood components
7: Specifications for blood components
8: Evaluation of novel blood components, production processes and blood packs: generic protocols
9: Microbiology tests for donors and donations: general specifications for laboratory test procedures
10: Investigation of suspected transfusion-transmitted infection
11: Reagent manufacture
12: Donation testing (red cell immunohaematology)
13: Patient testing (red cell immunohaematology)
14: Guidelines for the use of DNA/PCR techniques in Blood Establishments
15: Molecular typing for red cell antigens
16: HLA typing and HLA serology
17: Granulocyte immunology
18: Platelet immunology
19: Tissue banking: general principles
20: Tissue banking: selection of donors
21: Tissue banking: tissue retrieval and processing
22: Haemopoietic progenitor cells
23: Specification for the uniform labelling of blood, blood components and blood donor samples
24: Specification for the uniform labelling of human tissue products using ISBT 128
25: Standards for electronic data interchange within the UK Blood Transfusion Services
26: Specification for blood pack base labels
27: Specification for labelling consumables used in therapeutic product production
Annex 1: Standards available from the National Institute for Biological Standards and Control
Annex 2: ISBT 128 check character calculation
Annex 3 -Trial Components
Definitions
Abbreviations
Donor Selection
Guidelines
Welcome
DSG Definitions
National Help Lines
Bone Marrow and Peripheral Blood Stem Cell
Cord Blood
Geographical Disease Risk Index
Tissue - Deceased Donors
Tissue - Live Donors
Whole Blood and Components
Transfusion
Handbook
Welcome
Publication Information
Figures:
Tables
Preface
Contents
1: Transfusion ten commandments
2: Basics of blood groups and antibodies
3: Providing safe blood
4: Safe transfusion – right blood, right patient, right time and right place
5: Adverse effects of transfusion
6: Alternatives and adjuncts to blood transfusion
7: Effective transfusion in surgery and critical care
8: Effective transfusion in medical patients
9: EFFECTIVE transfusion in obstetric practice
10: Effective transfusion in paediatric practice
11: Therapeutic apheresis
12: Management of patients who do not accept transfusion
13: Appendices
14: Abbreviations and Glossary
Transfusion
Practice
UK Cell Salvage Action Group
Consent for Blood Transfusion
Regulations &
Implementation
Toolkit
Quality Management Systems
Cold Chain
GMP
Self Inspection
Traceability
Education
MHRA Process
QMS Specification
EU Blood Inspection
MHRA Aide Memoir
Aide Memoir Interpretations\Clarifications
MHRA Inspection Process
MHRA Roadshow Presentations
Clarification
Storage and Distribution
Documentation
Documentation Issues
Traceability in Emergency Situations
Traceability update 2014
IT
Principles of the EI Guidance Issued by the MHRA
Merging Patient Records
MHRA Guidance on Transfusion IT Systems
Training and Competency
Training Issues
Retaining Competency Assessments
Other
PFI Owned Equipment
Inspections
Major Non Compliances Listing
Feedback
Updates
MHRA BCC
Other
Questions from the TAG meeting
Archive
MHRA requirements
OIG Report
Terms of Reference
Education & Training
Systematic Review
Initiative
SRI Publications
Transfusion Evidence Library
About Us
UK Transfusion
Committees
National Blood Transfusion Committee
About the NBTC
Better Blood Transfusion
Business Documents
Calendar
Collaborations
Patient Blood Management
Patient Blood Management Conference
Responses and Recommendations
Transfusion Awareness
Do you know who I am?
RhD Haemolytic Disease of the Newborn
Working Groups
NSPA SPN 14: Implementation toolkit
Transfusion Laboratory Managers
Regional Transfusion Committees
East of England
East Midlands
London
North East
North West
South Central
South East Coast
South West
West Midlands
Yorkshire & The Humber
Home
/
Guidelines for the Blood Transfusion Services
/
12.1: Scope
Welcome
Latest Updates
Publication Information
Figures
Tables
Preface
Change Notifications
Contents
1:
Introduction
2:
Quality in blood and tissue establishments and hospital blood banks
3:
Care and selection of whole blood and component donors (including donors of pre-deposit autologous blood)
4:
Premises and quality assurance at blood donor sessions
5:
Collection of a blood or component donation
6:
Evaluation and manufacture of blood components
7:
Specifications for blood components
8:
Evaluation of novel blood components, production processes and blood packs: generic protocols
9:
Microbiology tests for donors and donations: general specifications for laboratory test procedures
10:
Investigation of suspected transfusion-transmitted infection
11:
Reagent manufacture
12:
Donation testing (red cell immunohaematology)
12.1:
Scope
12.2:
General requirements
12.3:
Samples
12.4:
Reagents and test kits
12.5:
Equipment
12.6:
Test procedure
12.7:
Reporting of results
12.8:
Release of tested components
12.9:
Laboratory test categories
12.10:
Mandatory testing of blood donations
12.11:
Additional testing
12.12:
Donations found to have a positive direct antiglobulin test
12.13:
Automated testing
12.14:
Manual testing
13:
Patient testing (red cell immunohaematology)
14:
Guidelines for the use of DNA/PCR techniques in Blood Establishments
15:
Molecular typing for red cell antigens
16:
HLA typing and HLA serology
17:
Granulocyte immunology
18:
Platelet immunology
19:
Tissue banking: general principles
20:
Tissue banking: selection of donors
21:
Tissue banking: tissue retrieval and processing
22:
Haemopoietic progenitor cells
23:
Specification for the uniform labelling of blood, blood components and blood donor samples
24:
Specification for the uniform labelling of human tissue products using ISBT 128
25:
Standards for electronic data interchange within the UK Blood Transfusion Services
26:
Specification for blood pack base labels
27:
Specification for labelling consumables used in therapeutic product production
Annex 1:
Standards available from the National Institute for Biological Standards and Control
Annex 2:
ISBT 128 check character calculation
Annex 3 -Trial Components
Definitions
Abbreviations
12.1: Scope
These specifications provide guidance on the tests required for blood donations in the UK.